New developments in prion disease research using genetically modified mouse models

被引:3
|
作者
Sun, Julianna L. L. [1 ]
Telling, Glenn C. C. [1 ]
机构
[1] Colorado State Univ, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA
基金
美国国家卫生研究院;
关键词
Prions; Strains; Chronic wasting disease; Transgenic mice; Gene-targeted mice; CHRONIC WASTING DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; MICE EXPRESSING HUMAN; TRANSGENIC MICE; MULE DEER; VARIANT CJD; STRAIN VARIATION; SPECIES-BARRIER; TRANSMISSION;
D O I
10.1007/s00441-023-03761-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
While much of what we know about the general principles of protein-based information transfer derives from studies of experimentally adapted rodent prions, these laboratory strains are limited in their ability to recapitulate features of human and animal prions and the diseases they produce. Here, we review how recent approaches using genetically modified mice have informed our understanding of naturally occurring prion diseases, their strain properties, and the factors controlling their transmission and evolution. In light of the increasing importance of chronic wasting disease, the application of mouse transgenesis to study this burgeoning and highly contagious prion disorder, in particular recent insights derived from gene-targeting approaches, will be a major focus of this review.
引用
收藏
页码:33 / 46
页数:14
相关论文
共 50 条
  • [21] Researchers Trigger Prion Formation in Mouse Models of Disease
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (13): : 1331 - 1331
  • [22] Genetically Engineered Mouse Models of Gliomas: Technological Developments for Translational Discoveries
    Noorani, Imran
    CANCERS, 2019, 11 (09)
  • [23] Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease
    Kobayashi, DT
    Chen, KS
    GENES BRAIN AND BEHAVIOR, 2005, 4 (03) : 173 - 196
  • [24] The utility of genetically altered mouse models for cancer research
    Donehower, LA
    French, JE
    Hursting, SD
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005, 576 (1-2) : 1 - 3
  • [25] Genetically modified mouse models for premature ovarian failure (POF)
    Jagarlamudi, Krishna
    Reddy, Pradeep
    Adhikari, Deepak
    Liu, Kui
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 315 (1-2) : 1 - 10
  • [26] Genetically modified mouse models for oral drug absorption and disposition
    Tang, Seng Chuan
    Hendrikx, Jeroen J. M. A.
    Beijnen, Jos H.
    Schinkel, Alfred H.
    CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (06) : 853 - 858
  • [27] Genetically modified mouse models in studies on cutaneous wound healing
    Scheid, A
    Meuli, M
    Gassmann, M
    Wenger, RH
    EXPERIMENTAL PHYSIOLOGY, 2000, 85 (06) : 687 - 704
  • [28] Contribution of genetically modified mouse models to the elucidation of bone physiology
    Thomas, T
    Lafage-Proust, MH
    REVUE DU RHUMATISME, 1999, 66 (12): : 728 - 735
  • [29] Genetically modified mouse models in studies of luteinising hormone action
    Huhtaniemi, Ilpo
    Ahtiainen, Petteri
    Pakarainen, Tomi
    Rulli, Susana B.
    Zhang, Fu-Ping
    Poutanen, Matti
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 252 (1-2) : 126 - 135
  • [30] The relevance of genetically altered mouse models of human disease
    Bhogal, Nirmala
    Combes, Robert
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2006, 34 (04): : 429 - 454